Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Taro Pharma OTC allergy drug gets FDA approval
Cetirizine Oral Solution is an antihistamine, indicated for the relief sneezing, runny nose, itchy, watery eyes and itchy throat or nose due to indoor and outdoor allergies and
Cetirizine Oral Solution is an antihistamine, indicated for the relief sneezing, runny nose, itchy, watery eyes and itchy throat or nose due to indoor and outdoor allergies and
The company has recruited around 90 patients at four sites which include Mount Sinai School of Medicine in New York City, Wake Research Associates in Raleigh, NC, Dermatology
Skystar has reported a net income of $1.93m, or $0.27 per diluted share, compared to net income of $1.1m or $0.15 per diluted share, for the same period
The active principal Proveblue is compliant with the monograph of the European pharmacopoeia and to ICH Q3A standards on impurities in new active substances. With is approval, Provepharm
ICON Cytometry Services’ full service solution allows clients to collaborate with the company at the early stages of development to create compound-specific assays. Clients work with ICON Central
INCIVEK is an oral medicine that acts directly on the hepatitis C virus protease, an enzyme essential for viral replication. The approval of INCIVEK was based on data
The company’s decision follows the approval from a Safety Review Committee which has evaluated the safety data from the first group of healthy subjects. The clinical trial protocol
At the new Indianapolis facility, Advion will focus on the earlier stage, drug discovery and metabolism bioanalytical services which evaluate how a potential new medicine is absorbed and
Brazil- based Vetec is a supplier of high quality specialty chemicals for the academic and industrial markets and provides products that support research, development and manufacturing. Vetec brings
Denosumab specifically targets RANK Ligand, an essential regulator of osteoclasts (the cells that break down bone). By targeting RANK Ligand regulator, denosumab has shown the ability to prevent